Skip to main content
Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada flag Canada · Delayed Price · Currency is CAD
0.160
-0.005 (-3.03%)
Apr 28, 2026, 3:59 PM EST

Pharmala Biotech Holdings Cash Flow Statement

Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year
 TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Feb '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Net Income
-1.63-2.18-0.82-0.78-0.99-3.76
Depreciation & Amortization
0.020.050.0100.010
Other Amortization
0.10.060.060.05--
Loss (Gain) on Equity Investments
-0.02----
Stock-Based Compensation
0.591.030.650.070.240.21
Provision & Write-off of Bad Debts
-0.19-0.190.020.02--
Other Operating Activities
0-0.020.16-0.07-3.13
Change in Accounts Receivable
-0.120.11-0.01-0.11-0.02-
Change in Inventory
-0.04-0.02-0.23-0.01-0.12-
Change in Accounts Payable
0.12-0-0.030.210.230.21
Change in Unearned Revenue
----0.05-
Change in Other Net Operating Assets
0.230.08-0.120.28-0.03-0.04
Operating Cash Flow
-0.92-1.04-0.32-0.34-0.63-0.26
Capital Expenditures
-0-0---0-0
Cash Acquisitions
-----1.34
Sale (Purchase) of Intangibles
-0.04-0.03-0.23-0.51-0.99-
Investment in Securities
0.81-0.9----
Other Investing Activities
------0.39
Investing Cash Flow
0.77-0.94-0.23-0.51-0.990.94
Issuance of Common Stock
-1.630.830.19-0.15
Other Financing Activities
--0.03-0.05--2.88
Financing Cash Flow
-01.60.770.19-3.03
Net Cash Flow
-0.15-0.380.22-0.66-1.623.71
Free Cash Flow
-0.92-1.05-0.32-0.34-0.63-0.26
Free Cash Flow Margin
-103.57%-172.85%-31.04%-63.84%-804.87%-
Free Cash Flow Per Share
-0.01-0.01-0.00-0.00-0.01-0.01
Levered Free Cash Flow
-0.31-0.17-0.08-0.48-1.18-
Unlevered Free Cash Flow
-0.31-0.17-0.08-0.48-1.18-
Change in Working Capital
0.190.17-0.40.380.110.16
Source: S&P Capital IQ. Standard template. Financial Sources.